These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20172070)

  • 81. Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy.
    Razavi S; Souied EH; Cavallero E; Weber M; Querques G
    Am J Ophthalmol; 2014 Apr; 157(4):852-60. PubMed ID: 24412124
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Photodynamic therapy for variant central serous chorioretinopathy: efficacy and side effects.
    Gupta B; Mohamed MD
    Ophthalmologica; 2011; 225(4):207-10. PubMed ID: 21325872
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: A 3-year follow-up study.
    Haga F; Maruko R; Sato C; Kataoka K; Ito Y; Terasaki H
    PLoS One; 2017; 12(7):e0181479. PubMed ID: 28742138
    [TBL] [Abstract][Full Text] [Related]  

  • 84. SUBFOVEAL CHOROIDAL THICKNESS CHANGES IN TREATED IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHY AND THEIR ASSOCIATION WITH RECURRENCE.
    Kim DY; Joe SG; Yang HS; Lee JY; Kim JG; Yoon YH
    Retina; 2015 Sep; 35(9):1867-74. PubMed ID: 25946693
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparison of Indocyanine Green Angiography and Fluorescein Angiography for Imaging of Central Serous Chorioretinopathy Patients as Candidates for Photodynamic Therapy.
    Kianersi F; Masjedi M; Razmjoo H; Ghanbari H; Fazel F; Dehghani A; Akhlaghi M; Salehi A; Baghi A; Pourazizi M
    J Fr Ophtalmol; 2022 Mar; 45(3):338-343. PubMed ID: 35063294
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy.
    Russo A; Turano R; Morescalchi F; Gambicorti E; Cancarini A; Duse S; Costagliola C; Semeraro F
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1141-1148. PubMed ID: 28283732
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.
    Scholz P; Altay L; Fauser S
    Eye (Lond); 2016 Oct; 30(10):1371-1377. PubMed ID: 27391938
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
    Schmidt-Erfurth UM; Michels S
    Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography.
    Quaranta-El Maftouhi M; El Maftouhi A; Eandi CM
    Am J Ophthalmol; 2015 Sep; 160(3):581-587.e1. PubMed ID: 26133250
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Photodynamic therapy of circumscribed choroidal hemangioma.
    Porrini G; Giovannini A; Amato G; Ioni A; Pantanetti M
    Ophthalmology; 2003 Apr; 110(4):674-80. PubMed ID: 12689885
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Evaluation of the choroid in central serous chorioretinopathy].
    Maruko I
    Nippon Ganka Gakkai Zasshi; 2012 Nov; 116(11):1062-79. PubMed ID: 23316655
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Photodynamic therapy for chronic central serous chorioretinopathy.
    Cardillo Piccolino F; Eandi CM; Ventre L; Rigault de la Longrais RC; Grignolo FM
    Retina; 2003 Dec; 23(6):752-63. PubMed ID: 14707823
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.
    Chan WM; Lam DS; Lai TY; Tam BS; Liu DT; Chan CK
    Br J Ophthalmol; 2003 Dec; 87(12):1453-8. PubMed ID: 14660450
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Quantification of metamorphopsia in chronic central serous chorioretinopathy after half-dose verteporfin photodynamic therapy.
    Fujita K; Imamura Y; Shinoda K; Matsumoto CS; Mizutani Y; Mizota A; Yuzawa M
    Retina; 2014 May; 34(5):964-70. PubMed ID: 24406387
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial.
    van Rijssen TJ; van Dijk EHC; Scholz P; Breukink MB; Dijkman G; Peters PJH; Tsonaka R; MacLaren RE; Downes SM; Fauser S; Boon CJF; Hoyng CB
    Am J Ophthalmol; 2020 Aug; 216():80-89. PubMed ID: 32289294
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A two-year study of diffused retinal pigment epitheliopathy treated with half-dose photodynamic therapy guided by simultaneous angiography and optical coherence tomography.
    Liu Y; Li L; Zhu EY; Yuan Y; Wang W; Xu G
    Eye (Lond); 2019 May; 33(5):737-745. PubMed ID: 30531992
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin.
    Zhao MW; Zhou P; Xiao HX; Lv YS; Li CA; Liu GD; Li XX
    Retina; 2009 Sep; 29(8):1155-61. PubMed ID: 19629018
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Modified Photodynamic Therapy Treatment of Central Serous Chorioretinopathy.
    Putnam CM; Vang SS
    Optom Vis Sci; 2016 Jul; 93(7):760-71. PubMed ID: 27058592
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Assessment of the efficacy of photodynamic therapy in patients with chronic central serous chorioretinopathy.
    Manethová K; Ernest J; Hrevuš M; Jirásková N
    Cesk Slov Oftalmol; 2020; 75(6):298-308. PubMed ID: 32911945
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy.
    Pang CE; Shah VP; Sarraf D; Freund KB
    Am J Ophthalmol; 2014 Aug; 158(2):362-371.e2. PubMed ID: 24794091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.